Temporal dynamics of MDRO eradication after FMT
FMT 后 MDRO 根除的时间动态
基本信息
- 批准号:10378130
- 负责人:
- 金额:$ 19.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:16S ribosomal RNA sequencingActive SitesAddressAnaerobic BacteriaAntibioticsAntimicrobial ResistanceBacteriaBacterial Antibiotic ResistanceBacterial Drug ResistanceBacteriophagesBenchmarkingBiomedical ResearchCenters for Disease Control and Prevention (U.S.)Cessation of lifeClinicalClinical ResearchClinical TrialsClostridium difficileCollaborationsCollectionComplementControl GroupsDataData ScienceData ScientistDevelopmentDiseaseEducational workshopEnterobacteriaceaeEnvironmentFecesFrequenciesFundingFutureGenesGoalsGoldInfectionInstitutionIntestinesInvestigationK-Series Research Career ProgramsKidney TransplantationLactamaseLinkMentorsMentorshipMetabolic PathwayMetabolismMetagenomicsMethodsMicrobiologyMorbidity - disease rateOrganismParticipantPatientsPersonsPharmaceutical PreparationsPrevalenceProcessPublic HealthPythonsRandomizedRandomized Controlled Clinical TrialsRecurrenceRefractoryResearchResourcesRiskSafetySamplingTechniquesTestingTherapeuticTimeTrainingTranslatingTransplant RecipientsUnited StatesViralVirulenceVirusWorld Health Organizationantimicrobial peptideantimicrobial resistant infectionapprenticeshipbacteriocinbasecarbapenem-resistant Enterobacteriaceaecareercareer developmentclinical applicationcolonization resistancedesigndrug developmenteffective therapyfecal transplantationgenome sequencingglobal healthgut colonizationgut microbiotaimprovedinfection riskknowledge basemicrobialmicrobiomemortalitymulti-drug resistant pathogennephrotoxicitynext generation sequencingnoveloperational taxonomic unitspre-clinicalprogramspublic health interventionresistance genetherapeutic developmenttoolviromewhole genome
项目摘要
PROJECT SUMMARY
The World Health Organization and U.S. Centers for Disease Control and Prevention have designated
antimicrobial resistance a major threat to Global Health with over 23,000 annual deaths related to antimicrobial
resistant infections in the U.S. alone. However, the drug pipeline to develop new antibiotics is dry. Small
studies support the safety and efficacy of fecal microbiota transplantation (FMT) to eliminate intestinal
colonization with antibacterial resistant organisms but its mechanisms are not well understood. We will
leverage patient-linked samples from a clinical trial PREMIX (NCT02922816) to test our overarching
hypothesis that anaerobic bacteria, viruses, and their gene-predicted functions are causally associated with
decreased MDRO colonization after FMT. The Specific Aims of this proposal include: Aim 1: Use the clinical
gold standard of bacterial culture to estimate efficacy of FMT in MDRO eradication. Aim 2A: Establish a novel
metagenomic analytic pipeline (MAP) to quantify abundance of bacterial and viral taxa, AR, virulence, and
colonization resistance genes. Aim 2B: Use 16S rRNA sequencing to estimate temporal dynamics of difficult to
culture bacterial taxa in FMT vs controls. Aim 2C: Use metagenomic whole-genome sequencing and the MAP
to estimate temporal dynamics of AR, virulence, and colonization resistance genes in FMT vs controls. Aim 3:
Use environmental virome NGS techniques to test the association of viral (including bacteriophage) taxa with
abundance of MDRO after FMT. We expect that completion of these aims and related training will lead to
clinically applicable preliminary data and next steps in translational microbial therapeutic development for
MDRO colonization. My long-term career goal is to become a collaborative leader in ID microbiome data
science focusing on: 1) mechanisms of microbial therapeutics such as FMT in reducing colonization with multi-
drug resistant organisms (MDRO), and 2) translating these findings into clinical and public health interventions
to reduce MDRO colonization and infection. Emory and Georgia Tech are ideal and highly-collaborative
research environments, which are both national leaders in biomedical research. Both institutions provide rich
resources to complete the described aims and progress in career development to become an independent
translational ID microbiome data scientist. In addition, Emory is an active site of microbial therapeutic
investigation with 7 clinical trials of microbial therapeutics and a clinical FMT program that has completed over
300 treatments for refractory Clostridioides difficile.
项目摘要
世界卫生组织和美国疾病控制和预防中心已指定
抗生素耐药性是全球健康的主要威胁,每年有超过23,000例与抗生素相关的死亡
仅在美国就出现了耐药感染。然而,开发新抗生素的药物管道是干燥的。小
研究支持粪便微生物群移植(FMT)的安全性和有效性,
抗细菌耐药生物体的定殖,但其机制还不清楚。我们将
利用来自临床试验PREMIX(NCT 02922816)的患者相关样本,
假设厌氧细菌,病毒和它们的基因预测功能与
FMT后MDRO定植减少。本提案的具体目的包括:目的1:使用临床
细菌培养的金标准,以评估FMT在MDRO根除中的疗效。目标2A:建立一个新的
宏基因组分析管道(MAP),用于量化细菌和病毒分类群、AR、毒力和
定植抗性基因目的2B:使用16 S rRNA测序来估计难以预测的时间动态。
培养细菌分类群FMT与对照。目标2C:使用宏基因组全基因组测序和MAP
估计FMT与对照组中AR、毒力和定殖抗性基因的时间动态。目标3:
使用环境病毒组NGS技术测试病毒(包括噬菌体)分类群与
FMT后的MDRO丰度。我们期望,完成这些目标和相关培训将导致
临床适用的初步数据和转化微生物治疗开发的下一步
MDRO殖民化。我的长期职业目标是成为ID微生物组数据的协作领导者
科学集中于:1)微生物治疗的机制,如FMT在减少与多-
耐药微生物(MDRO),以及2)将这些发现转化为临床和公共卫生干预措施
以减少MDRO定植和感染。埃默里大学和格鲁吉亚理工大学是理想的、高度合作的学校
研究环境,这两个国家的领导人在生物医学研究。两家机构都提供丰富的
资源来完成所描述的目标和职业发展的进展,成为一个独立的
翻译ID微生物组数据科学家。此外,埃默里是微生物治疗的活性部位
7项微生物治疗临床试验和一项临床FMT计划的调查,该计划已完成超过
治疗难治性艰难梭菌300例。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Holmes Woodworth其他文献
Michael Holmes Woodworth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Holmes Woodworth', 18)}}的其他基金
Temporal dynamics of MDRO eradication after FMT
FMT 后 MDRO 根除的时间动态
- 批准号:
10598519 - 财政年份:2019
- 资助金额:
$ 19.15万 - 项目类别:
相似海外基金
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 19.15万 - 项目类别:
Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 19.15万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 19.15万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 19.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 19.15万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 19.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 19.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 19.15万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 19.15万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 19.15万 - 项目类别:
Discovery Grants Program - Individual